DEA Adds Metonitazene to Schedule I Drug List
The Drug Enforcement Administration permanently placed the synthetic benzimidazol-opioid metonitazene on Schedule I of the Controlled Substances Act, it said in a final order released Aug. 17. The substance had already been temporarily listed in Schedule I since 2022 (see…
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
2204110029). The final order is set to take effect Sept. 18.